Utilizing the same validated shRNA targeting NSD1, we achieved effective knockdown, as confirmed by Western blot analysis (Figure 1B,C) using three histologically different cell lines for RPPA validation: JHU 011, laryngeal, Cal27, tongue and FaDu, hypopharyngeal squamous cell carcinoma cell lines. Here, NSD1 is linked to squamous cell carcinoma.